Downing Healthcare Ventures
We invest in tech-enabled healthcare companies that improve access to high-quality care, positively impact clinical outcomes and reduce the cost of delivery for patients worldwide.
Get in touch with the team
Downing Healthcare Ventures
We invest in tech-enabled health solutions that deliver value and impact now. Downing's Healthcare Ventures team is led by Dr Nigel Pitchford, who has significant operational and investment expertise - giving us a unique edge in the sector.
By having a deep thematic focus on healthcare, we believe we can generate attractive returns for investors looking to transform healthcare systems everywhere.
18 businesses*
within the current portfolio
*as at March 2023
Due to a number of trends such as ageing populations, increased demand, covid-induced pressures and workforce challenges, healthcare systems are in crisis -leading to a significant negative impact on patients. This has created a market opportunity for late-stage venture-backed healthcare companies to improve efficiencies and bring to market new technology to alleviate the ongoing strain.
Over the last 100+ years, healthcare has developed and transformed as technology has improved. Healthcare is on the verge of evolving once again as it becomes smarter, more personalised and the point of care changes. Much like the preceding eras, this will create new industries, leaders and eventually giants.
The UK is a global leader in healthtech and home to the largest number of digital start-ups in Europe since 2010. Its world-class science and research capabilities act as a foundation for leading health science companies to break new ground. With a combination of early-stage venture capital and re-affirmed NHS goals towards a digital care future, the opportunity set is widening.
Making an impact
Our approach focuses on backing companies that contribute to the United Nations Sustainable Development Goals (SDGs), particularly SDG3 - "to ensure healthy lives and promote well-being for all at all ages." We see the greatest impact in three ways: better access to clinical care; improved clinical outcomes for patients; and reduced costs. Ultimately, however, the best indicator of positive impact will be improved quality of life for patients.
Portfolio case studies
View moreInsights
View more
Meet the team
If you would like to find out more about the Healthcare Ventures team, please click the link below.
Meet the team
Downing LLP does not provide advice or make personal recommendations and investors are strongly urged to seek independent advice before investing. Investments offered on this website carry a higher risk than many other types of investment and prospective investors should be aware that capital is at risk and the value of their investment may go down as well as up. Any investment should only be made on the basis of the relevant product literature and your attention is drawn to the risk, fees and taxation factors contained therein. Tax treatment depends on individual circumstances of each investor and may be subject to change in the future. Past performance is not a reliable indicator of future performance. Downing LLP is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 545025). Registered in England No. OC341575. Registered Office: St Magnus House, 3 Lower Thames Street, London EC3R 6HD.
VAT Number: 112 940 149
